title: Weekly paclitaxel may improve locoregional recurrence by decreasing interstitial fluid pressure in operable node-positive breast cancer patients.
authors.forename: Kadri
authors.initials: K
authors.lastname: Altundag
authors.forename: Ozden
authors.initials: O
authors.lastname: Altundag
authors.forename: Cem
authors.initials: C
authors.lastname: Boruban
authors.forename: Muzaffer B
authors.initials: MB
authors.lastname: Altundag
authors.forename: Selahattin
authors.initials: S
authors.lastname: Turen
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology* / Q000627:therapeutic use; D001943:Breast Neoplasms; D004305:Dose-Response Relationship, Drug; D045604:Extracellular Fluid / Q000187:drug effects*; D005260:Female; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy* / Q000517:prevention & control*; D017239:Paclitaxel / Q000494:pharmacology* / Q000627:therapeutic use; D011312:Pressure
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel